JP2009534332A5 - - Google Patents

Info

Publication number

JP2009534332A5

JP2009534332A5 JP2009505767A JP2009505767A JP2009534332A5 JP 2009534332 A5 JP2009534332 A5 JP 2009534332A5 JP 2009505767 A JP2009505767 A JP 2009505767A JP 2009505767 A JP2009505767 A JP 2009505767A JP 2009534332 A5 JP2009534332 A5 JP 2009534332A5

Authority

JP

Japan

Prior art keywords

hpv

composition

polypeptide

amino acid

acid sequence

Prior art date

2007-04-17

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Withdrawn

Links

• Espacenet
• Global Dossier
• Discuss

• 229920001184 polypeptide Polymers 0.000 claims 23
• 108090000765 processed proteins & peptides Proteins 0.000 claims 23
• 102000004196 processed proteins & peptides Human genes 0.000 claims 23
• 241000341655 Human papillomavirus type 16 Species 0.000 claims 13
• 125000003275 alpha amino acid group Chemical group 0.000 claims 8
• 108020004707 nucleic acids Proteins 0.000 claims 8
• 102000039446 nucleic acids Human genes 0.000 claims 8
• 150000007523 nucleic acids Chemical class 0.000 claims 8
• 101000954493 Human papillomavirus type 16 Protein E6 Proteins 0.000 claims 6
• 101000767631 Human papillomavirus type 16 Protein E7 Proteins 0.000 claims 6
• 108090000695 Cytokines Proteins 0.000 claims 3
• 102000004127 Cytokines Human genes 0.000 claims 3
• 241000701806 Human papillomavirus Species 0.000 claims 3
• 206010046865 Vaccinia virus infection Diseases 0.000 claims 3
• 231100001223 noncarcinogenic Toxicity 0.000 claims 3
• 230000001575 pathological effect Effects 0.000 claims 3
• 208000007089 vaccinia Diseases 0.000 claims 3
• 206010008263 Cervical dysplasia Diseases 0.000 claims 2
• 101100232904 Homo sapiens IL2 gene Proteins 0.000 claims 2
• 101100321817 Human parvovirus B19 (strain HV) 7.5K gene Proteins 0.000 claims 2
• 208000007951 cervical intraepithelial neoplasia Diseases 0.000 claims 2
• 208000015181 infectious disease Diseases 0.000 claims 2
• 239000012528 membrane Substances 0.000 claims 2
• 230000003248 secreting effect Effects 0.000 claims 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
• 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 claims 1
• 206010061424 Anal cancer Diseases 0.000 claims 1
• 208000007860 Anus Neoplasms Diseases 0.000 claims 1
• 206010008342 Cervix carcinoma Diseases 0.000 claims 1
• 108090000288 Glycoproteins Proteins 0.000 claims 1
• 102000003886 Glycoproteins Human genes 0.000 claims 1
• 241000725303 Human immunodeficiency virus Species 0.000 claims 1
• 108010002350 Interleukin-2 Proteins 0.000 claims 1
• 102000000588 Interleukin-2 Human genes 0.000 claims 1
• 241000712079 Measles morbillivirus Species 0.000 claims 1
• 208000003445 Mouth Neoplasms Diseases 0.000 claims 1
• 206010028980 Neoplasm Diseases 0.000 claims 1
• 241001631646 Papillomaviridae Species 0.000 claims 1
• 208000037581 Persistent Infection Diseases 0.000 claims 1
• 208000006994 Precancerous Conditions Diseases 0.000 claims 1
• 101900083372 Rabies virus Glycoprotein Proteins 0.000 claims 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
• 201000011165 anus cancer Diseases 0.000 claims 1
• 201000011510 cancer Diseases 0.000 claims 1
• 210000000170 cell membrane Anatomy 0.000 claims 1
• 201000010881 cervical cancer Diseases 0.000 claims 1
• 230000037430 deletion Effects 0.000 claims 1
• 238000012217 deletion Methods 0.000 claims 1
• 230000028993 immune response Effects 0.000 claims 1
• 230000001939 inductive effect Effects 0.000 claims 1
• 238000007918 intramuscular administration Methods 0.000 claims 1
• 208000012987 lip and oral cavity carcinoma Diseases 0.000 claims 1
• 230000002265 prevention Effects 0.000 claims 1
• 238000007920 subcutaneous administration Methods 0.000 claims 1
• 230000003442 weekly effect Effects 0.000 claims 1